Abstract
In this editorial, we explore the profound implications of Donald Trump's re-election on the U.S. health policy landscape. Recalling the lessons of his first term, marked by a contentious response to COVID-19 and challenges in reducing healthcare costs, we assess the potential trajectories of his administration's health agenda. With a focus on deregulation, market-based approaches, and possible shifts in public health infrastructure, the stakes are high not only for American citizens but also for global health. As Trump's policies unfold, both national and international audiences must confront a complex future that tests resilience, equity, and public trust in health governance.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The International journal of health planning and management
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
